These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23577324)

  • 1. Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor.
    Hawkins-Daarud A; Rockne RC; Anderson AR; Swanson KR
    Front Oncol; 2013; 3():66. PubMed ID: 23577324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.
    Swanson KR; Chakraborty G; Wang CH; Rockne R; Harpold HL; Muzi M; Adamsen TC; Krohn KA; Spence AM
    J Nucl Med; 2009 Jan; 50(1):36-44. PubMed ID: 19091885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.
    de Groot JF; Fuller G; Kumar AJ; Piao Y; Eterovic K; Ji Y; Conrad CA
    Neuro Oncol; 2010 Mar; 12(3):233-42. PubMed ID: 20167811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.
    Kamson DO; Juhász C; Buth A; Kupsky WJ; Barger GR; Chakraborty PK; Muzik O; Mittal S
    J Neurooncol; 2013 Mar; 112(1):121-32. PubMed ID: 23299463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in MRI assessment of gliomas and response to anti-VEGF therapy.
    Pope WB; Young JR; Ellingson BM
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):336-44. PubMed ID: 21234719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences.
    Tien RD; Felsberg GJ; Friedman H; Brown M; MacFall J
    AJR Am J Roentgenol; 1994 Mar; 162(3):671-7. PubMed ID: 8109520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
    Oh J; Cha S; Aiken AH; Han ET; Crane JC; Stainsby JA; Wright GA; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2005 Jun; 21(6):701-8. PubMed ID: 15906339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
    Harris RJ; Cloughesy TF; Pope WB; Godinez S; Natsuaki Y; Nghiemphu PL; Meyer H; Paul D; Behbahanian Y; Lai A; Ellingson BM
    J Neurooncol; 2013 Apr; 112(2):257-66. PubMed ID: 23344788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIRE (high intensity reduction). New cerebrospinal fluid suppressed T2-weighted imaging sequence].
    Essig M; Deimling M; Schoenberg SO; Debus J; Knopp MV; van Kaick G
    Radiologe; 2000 Dec; 40(12):1163-71. PubMed ID: 11197935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging.
    Zhu XP; Li KL; Kamaly-Asl ID; Checkley DR; Tessier JJ; Waterton JC; Jackson A
    J Magn Reson Imaging; 2000 Jun; 11(6):575-85. PubMed ID: 10862055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of fluid suppression in intracranial postcontrast fluid-attenuated inversion recovery magnetic resonance imaging: A clinical and phantom study.
    Dickinson PJ; Jones-Woods S; Cissell DD
    Vet Radiol Ultrasound; 2018 Jul; 59(4):432-443. PubMed ID: 29424062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
    Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
    Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative fluid-attenuated inversion recovery MR imaging of cerebral gliomas: initial results.
    Essig M; Metzner R; Bonsanto M; Hawighorst H; Debus J; Tronnier V; Knopp MV; van Kaick G
    Eur Radiol; 2001; 11(10):2004-10. PubMed ID: 11702135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.
    Hattingen E; Jurcoane A; Daneshvar K; Pilatus U; Mittelbronn M; Steinbach JP; Bähr O
    Neuro Oncol; 2013 Oct; 15(10):1395-404. PubMed ID: 23925453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors.
    Tsuchiya K; Mizutani Y; Hachiya J
    AJNR Am J Neuroradiol; 1996; 17(6):1081-6. PubMed ID: 8791919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.